Related Experiment Video

Updated: Jun 2, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Chlamydia pneumoniae seropositivity in Iranian patients with multiple sclerosis: a pilot study

Maryam Aghaei1, Fereshteh Ashtari, Mohammadali Bahar

  • 1Science and Research Branch, Islamic Azad University, Tehran, Iran.

Neurologia I Neurochirurgia Polska
|May 17, 2011
PubMed
Abstract

Insights

This study found no link between Chlamydia pneumoniae infection and multiple sclerosis (MS) in Iranian patients. Researchers evaluated antibodies against C. pneumoniae in MS patients and controls, revealing no significant differences.

Area of Science:

  • Neurology
  • Immunology
  • Infectious Diseases

Background:

  • Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system.
  • The exact causes of MS remain unclear, with both genetic and environmental factors implicated.
  • Infectious agents are being investigated as potential environmental triggers for MS.

Purpose of the Study:

  • To investigate the potential role of Chlamydia pneumoniae (C. pneumoniae) in the development or progression of multiple sclerosis.
  • To evaluate the seropositivity of C. pneumoniae in patients diagnosed with MS.

Main Methods:

  • Serum samples were collected from 85 MS patients and 50 age- and sex-matched controls.
  • Enzyme-linked immunosorbent assay (ELISA) was used to measure IgM and IgG antibody concentrations for C. pneumoniae.
  • Statistical analysis was performed to compare antibody levels between MS patients and controls.

Main Results:

  • No significant difference in median C. pneumoniae IgM antibody concentrations was found between MS patients (0.5 RU/mL) and controls (0.5 RU/mL) (p = 0.66).
  • Median C. pneumoniae IgG antibody concentrations were also similar in MS patients (57.3 RU/mL) and controls (56.15 RU/mL) (p = 0.85).
  • No association was observed between C. pneumoniae IgG levels and the clinical course of MS (RRMS vs. SPMS).

Conclusions:

  • The study found no evidence of an association between Chlamydia pneumoniae infection and multiple sclerosis in the studied Iranian population.
  • These findings suggest that C. pneumoniae may not play a significant role in the pathogenesis of MS in this cohort.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...